Latest news
US generics tariffs more negotiation tactic than real threat: Biocon's Kiran Mazumdar-Shaw - TradingViewTradingView · Fri, 07 Aug 2026 03:33:00 GMTBiocon expects stronger second half on new biosimilar launches - CNBC TV18CNBC TV18 · Thu, 06 Aug 2026 11:42:04 GMTFrom a rented garage to a global biotech giant: How Kiran Mazumdar-Shaw built Biocon after being told wom - The Times of IndiaThe Times of India · Tue, 04 Aug 2026 03:22:00 GMTBicara Therapeutics Appoints Jeremy Bender and Christy Oliger to Board of Directors; Kiran Mazumdar-Shaw Retires - quiverquant.comquiverquant.com · Tue, 28 Jul 2026 07:00:00 GMT